How can Paxlovid affect oxycodone concentrations and the risk of respiratory depression?

Paxlovid's ritonavir inhibits CYP3A4 and is expected to increase oxycodone plasma concentrations, potentially increasing respiratory depression risk; if concurrent use is necessary, consider reducing the oxycodone dose and monitor therapeutic and adverse effects closely at frequent intervals.